These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3243658)

  • 1. Ibopamine kinetics after single and multiple dosing in patients with congestive heart failure.
    Azzollini F; De Caro L; Longo A; Pelosi G; Rolandi E; Ventresca GP; Lodola E
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):544-51. PubMed ID: 3243658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of ibopamine on different diseases and conditions.
    Ventresca GP; Lodola E
    Arzneimittelforschung; 1988 Aug; 38(8):1175-80. PubMed ID: 2904270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibopamine kinetics after a single oral dose in patients with congestive heart failure.
    Azzollini F; Cattò G; Iacuitti G; Pelosi G; Picca M; Pocchiari F; Pataccini R; Castelnovo P; Longo A; Ventresca GP
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):105-12. PubMed ID: 3410586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ibopamine in patients with renal impairment.
    Salvadeo A; Villa G; Bovio G; Pocchiari F; Pataccini R; Longo A; Ventresca GP
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):98-104. PubMed ID: 3410592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibopamine kinetics after a single oral dose in healthy volunteers.
    Lodola E; Borgia M; Longo A; Pocchiari F; Pataccini R; Sher D
    Arzneimittelforschung; 1986 Feb; 36(2A):345-8. PubMed ID: 3707647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats.
    Pocchiari F; Pataccini R; Castelnovo P; Longo A; Casagrande C
    Arzneimittelforschung; 1986 Feb; 36(2A):334-40. PubMed ID: 3707645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs.
    Pocchiari F; Pataccini R; Castelnovo P; Longo A; Paro M; Casagrande C
    Arzneimittelforschung; 1986 Feb; 36(2A):341-4. PubMed ID: 3707646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ibopamine metabolites in rat and dog urine.
    Kuo GY; Hwang BY; Lynn RK
    Drug Metab Dispos; 1988; 16(6):793-8. PubMed ID: 2907455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure.
    Vitolo E; Segalini G; Carini L; Castini D; Moreo A; Mazzola C; Segagni S; Villa G; Salvadeo A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):327-34. PubMed ID: 3209280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A; Mussini A; Bramucci E
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibopamine (SK&F 100168) pharmacokinetics in relation to the timing of meals.
    Scott SC; Locke-Haydon J; Pready NS; Buller NP; Cregeen RJ
    Br J Clin Pharmacol; 1987 May; 23(5):585-7. PubMed ID: 3593628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
    Wehling M; Zimmermann J; Weil J; Gerzer R; Theisen K
    Z Kardiol; 1990 Feb; 79(2):120-5. PubMed ID: 2157313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the bioequivalence of three oral formulations of ibopamine in healthy volunteers.
    Douchamps J; Juvent M; Vanschoubroek K; Seth A; Deger F; Derenne F; Herchuelz A
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):482-6. PubMed ID: 3069751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ibopamine--pharmacologic principles].
    Borchard U
    Z Kardiol; 1991; 80 Suppl 8():63-6. PubMed ID: 1686693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibopamine: long-term safety study in patients with congestive heart failure. The Italian Ibopamine Working Group.
    Riva E; Cavalli A; Abbondati G; Cedrini MC; Schleman M; Fuccella LM
    Int J Clin Pharmacol Res; 1989; 9(1):21-8. PubMed ID: 2707922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.